← Leaderboards
Robert K. Bright
Providence Portland Medical Center
$831,296
Attributed
$831,296
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $199.7K · FY2015–23$200K$150K$100K$50K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$831,296 · 3
By mechanism
R21$366,053 · 1
R29$312,243 · 1
R03$153,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Providence Portland Medical Center
Same institution · by research overlap
- Bernard A Fox$5,302,432
- Hong-Ming Hu$1,630,963
- Christian H Poehlein$391,829
- Marka Crittenden$2,669,247
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellProteinsCd8b1 GeneImmuneOverexpressionPreventImmunityClinical ApplicationBurden Of IllnessNeoplasm MetastasisMass Spectrum AnalysisAutoantigensMalignant - DescriptorLifeMissionCancer VaccinesBehaviorCellsOrganismAntigensGenerationsMonitorCancer PreventionRegulation
Grant awards (7)
"Post-translational modification of non-histone proteins as a mechanism of pMHC-I neo-ligand generation"$76,500
R03 · FY2023 · CA · contact PI
"Post-translational modification of non-histone proteins as a mechanism of pMHC-I neo-ligand generation"$76,500
R03 · FY2022 · CA · contact PI
Vaccination with the Tumor Self-Protein TP(D52) Elicits a Unique Subset of CD8+ T Cells$166,388
R21 · FY2016 · CA · contact PI
Vaccination with the Tumor Self-Protein TP(D52) Elicits a Unique Subset of CD8+ T Cells$199,665
R21 · FY2015 · CA · contact PI
T CELL FOCUSED CANCER VACCINES IN MURINE TUMOR MODELS$110,981
R29 · FY2002 · CA
T CELL FOCUSED CANCER VACCINES IN MURINE TUMOR MODELS$102,604
R29 · FY2001 · CA
T CELL FOCUSED CANCER VACCINES IN MURINE TUMOR MODELS$98,658
R29 · FY2000 · CA